The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A Streptococcus

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|13|1|22-27

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.13, Iss.1, 2016-12, pp. : 22-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccine Development for Group A Streptococcus Infections and Associated Diseases

By  

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Conformational Mimetics of Conserved Streptococcus Pyogenes Minimal Epitope as Vaccine Candidates

By  

Current Drug Delivery, Vol. 6, Iss. 5, 2009-10 ,pp. : 520-527

Bentham Science Publishers

Access to resources Recommend Favorite

Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus

By  

Current Drug Delivery, Vol. 14, Iss. 5, 2017-07 ,pp. : 701-708

Bentham Science Publishers

Access to resources Recommend Favorite

M-Protein-derived Conformational Peptide Epitope Vaccine Candidate against Group A Streptococcus

By  

Current Drug Delivery, Vol. 10, Iss. 1, 2013-02 ,pp. : 39-45

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Development of Group A Streptococcus Vaccines

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 11, 2013-11 ,pp. : 947-950

Bentham Science Publishers

Access to resources Recommend Favorite